Medical Newswire!

Health News Health News Headlines - Yahoo! News Get the latest health news headlines from Yahoo! News. Find breaking health news, including analysis and opinion on top health stories. Measles surges in UK years after vaccine scare 20 May 2013 at 5:37am LONDON (AP) ? More than a decade ago, British parents refused to give measles shots to at least a million children because of a vaccine scare that raised the specter of autism. Now, health officials are scrambling to catch up and stop a growing epidemic of the contagious disease. WHO says single yellow fever shot is enough 17 May 2013 at 2:10am GENEVA (AP) ? The World Health Organization says a yellow fever booster vaccination given 10 years after the initial shot isn't necessary. Tiny preemies get a boost from live music therapy 16 May 2013 at 1:16am CHICAGO (AP) ? As the guitarist strums and softly sings a lullaby in Spanish, tiny Augustin Morales stops squirming in his hospital crib and closes his eyes. Physician, hack thyself 20 May 2013 at 8:15am Biohackers are gulping down Dave Asprey's Bulletproof Coffee Breakfast. What the heck is it -- and more importantly, does it work? Actavis to buy Warner Chilcott in $5 billion stock deal 20 May 2013 at 7:46am By Caroline Humer (Reuters) - Generic drugmaker Actavis Inc, itself the subject of takeover speculation, said on Monday it would buy specialty pharmaceutical company Warner Chilcott Plc for $5 billion in stock to expand its branded drug portfolio, lower taxes and increase profits. Warner Chilcott brings a portfolio of branded women's health pharmaceuticals, such as the contraceptive patch to Actavis, which makes and sells drugs that are no longer under patent protection. ... What do we eat? New food map will tell us 20 May 2013 at 7:35am CHAPEL HILL, N.C. (AP) ? Do your kids love chocolate milk? It may have more calories on average than you thought. Measles surges in UK years after flawed research 20 May 2013 at 7:34am LONDON (AP) ? More than a decade ago, British parents refused to give measles shots to at least a million children because of now discredited research that linked the vaccine to autism. Now, health officials are scrambling to catch up and stop a growing epidemic of the contagious disease. UK tries out new model for gene testing in cancer patients 20 May 2013 at 7:31am By Kate Kelland LONDON (Reuters) - Britain launched a research program on Monday that should eventually allow all cancer patients to have access to the kind of genetic analysis that led Hollywood star Angelina Jolie to decide to undergo a double mastectomy. The project, involving the Institute of Cancer Research (ICR) in London, the U.S. gene sequencing firm Illumina, geneticists and cancer doctors, aims to find a way to allow more cancer genes be tested in more people. Researchers announcing the 2. ... AstraZeneca closes in on site for new home in Cambridge 20 May 2013 at 7:24am By Ben Hirschler and Tom Bill LONDON (Reuters) - AstraZeneca is closing in on a site for its new $500 million home in Cambridge, with a biomedical park just south of the English city the most likely site, property industry sources said. Moving research and global headquarters to Cambridge, with minimal disruption, is a key test for new Chief Executive Pascal Soriot as he tries to change the drugmaker's culture and puts ground-breaking science at the center of its activities. The move to the university city, involving nearly 2,000 jobs, is the centerpiece of a $2. ... Court: woman can seek lawyer fees in vaccine case 20 May 2013 at 7:21am WASHINGTON (AP) ? The Supreme Court says a woman can seek lawyers' fees from the government even though her lawsuit over damage she said was caused by a vaccine was ruled untimely. Supreme Court agrees to hear Medtronic patent case 20 May 2013 at 7:17am By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court on Monday agreed to hear a patent dispute concerning Medtronic Inc over medical devices it manufactures that give the heart electrical jolts when it fails to pump blood properly. Medtronic wants the Supreme Court to reverse an appeals court finding that it had the burden of showing that it was not infringing on patents owned by Mirowski Family Ventures LLC and licensed exclusively to Boston Scientific Corp. ... FDA staff says Merck's sleep drug effective, questions dosage 20 May 2013 at 7:16am By Toni Clarke (Reuters) - Merck & Co's experimental insomnia drug suvorexant appears generally effective, according to reviewers at the U.S. Food and Drug Administration, but they questioned the company's proposed dosing levels. The reviewers posted their comments on the FDA's website on Monday, two days ahead of a meeting of outside medical experts which will advise the agency on whether or not it should approve the drug. Merck's shares fell 1.1 percent to $45.47 in early trading. ... Peregrine Pharma agrees with FDA on lung cancer trial design 20 May 2013 at 6:40am (Reuters) - Peregrine Pharmaceuticals said it reached an agreement with the U.S. Food and Drug Administration on the design of a late-stage trial for its experimental lung cancer drug. The late-stage trial will compare a combination of chemotherapy and the drug, bavituximab, with chemotherapy alone. The main goal of the trial would be to show an improvement in overall survival of patients. Peregrine shares were up 19 percent at $1.83 in early trade on Monday on the Nasdaq. Bavituximab is being developed to treat second-line non-small-cell lung cancer and multiple other cancers. ... XenoPort to drop multiple sclerosis drug after trial failure 20 May 2013 at 5:32am (Reuters) - XenoPort Inc said it will stop developing its experimental multiple sclerosis treatment after data from a late-stage trial showed the drug did not improve patients' condition significantly compared with a placebo. Shares of the company were down 28 percent at $4.85 before the bell. The company said it would shut down all activities related to the drug, arbaclofen placarbil, and planned to provide an update on the impact of the expected savings. ... Brazilian killed in hot-air balloon crash in Turkey 20 May 2013 at 4:15am ISTANBUL (Reuters) - A hot-air balloon flying over Cappadocia, a tourist destination in central Turkey, crashed after colliding with another balloon on Monday, killing a Brazilian passenger and injuring 24 other people, the Anatolian news agency said. The accident occurred near the city of Nevsehir. Most of the injured were being treated for broken bones but one was in critical condition, Cappadocia is famous for its geological features called fairy chimneys. Balloon rides are a popular way to see the cone-like formations, created by the erosion of volcanic ash around them. ...